$3250 | Single User
$4650 | Site License
$5650 | Global License

Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270579 | In Stock
Related Topics: Boehringer Ingelheim , COVID , Drug , FDA , Pharmaceuticals , Retail , Vaccine

Introduction

REPORT HIGHLIGHT

The companion animal health market is estimated to represent a global market of USD 12,506 million by 2019 with growth rate of 4.8%.

Market Dynamics

Companion animal health industry includes all products and services (i.e. pet services, diagnostics and OTC health) for dogs, horses, cats, and others. The growth of this industry is majorly influenced by the strong increase in the rate of pet ownership. Further, rising strategic collaborations of companies with veterinary organizations to promote awareness and improve animal health augment the market growth significantly. For instance, in 2015, Ceva partnered with the America Association of Feline Practitioners, aimed to encourage pet owner to standardize animal research and surgery practices.

Over the past few years, research and development activities in the veterinary industry have increased and thus the spending on companion animal health. According to American Pet Product Association (APPA), companion animal spending has been consistently on the rise. The organization stated that in 2011, the spending on pet industry was around USD 51 billion and is expected to reach USD 69.36 billion by 2019. The statistics from APPA also stated that around 20.0% of this spending was found to be on over-the-counter products and food & supplies, whereas 25.0% was on veterinary care, including pharmaceuticals.

In May 2015, the Federal Trade Commission (FTC) also stated that the market for veterinary medicine has shown significant growth in recent years. The organization estimated that prescription and over the counter medicine for the dogs and cats are projected to increase with a significant growth rate over the future period. All such facts indicate the rise in adoption of companion animal therapeutics thus, augment the market growth.

COVID-19 Impact and Recovery Analysis

The novel COVID-19 has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. However, this market is positively affected due to this outbreak. This report presented by AnalystView Market Insights contains a thorough analysis of the pre and post COVID-19 market scenarios. The report includes all the recent development and changes recorded during the COVID-19 outbreak and comprehends the analysis of top performer segments and marginal growth segment in blood culture test sector.

Product Takeaway

Product segment is divided into Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others. Increasing research and development activities coupled with favorable government initiatives has helped pharmaceuticals segment to be on the top spot. Drugs segment is categorized into Over the Counter (OTC) and Prescription. Whereas, distribution channel segment is bifurcated into E-commerce, Retail, and Hospitals. The application segment is divided in terms of Clinics, Point-of-Care Facilities, and others.

Regional Takeaway

Regionally, North America accounted for the largest share, closely followed by Europe. Presence of a large number of established pharmaceutical companies that are consistently striving for extensive commercialization of their veterinary products is presumed to be a key factor responsible for growth in both regions. Asia Pacific region is projected to grow with the highest CAGR owing to the rise in adoption of companion animals coupled with the increasing disposable income.

Key Vendor Takeaway

Companies namely Merck, Nutreco, Zoetis, Boehringer Ingelheim, Bayer AG, and Virbac are profiled in detail. Among which, the most notable market participants are Nutreco, Bayer, and Zoetis, accounting for the majority of the revenue share. Key players operating in this market are majorly involved in the development of new products and strategic expansion of their geographic reach. For example, Zoetis offers products such as Cerenia, Convenia, Synulox, Dexdomitor, Cerenia, Palladia, and Rimadyl under companion animal therapeutics. Recently, in December 2016, US FDA approved company’s first monoclonal antibody product named “CYTOPOINT”. This drug act by neutralizing interleukin-31 (IL-31) and provide long-lasting relief from atopic dermatitis in dogs.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY ANIMAL TYPE

Equine

Dogs

Sheep & Goats

Cats

Poultry

MARKET, BY PRODUCT

Vaccines

Pharmaceuticals

Feed Additives

Diagnostics

Others

MARKET, BY DRUG

OTC

Prescription

MARKET, BY DISTRIBUTION CHANNEL

E-commerce

Retail

Hospitals

MARKET, BY APPLICATION

Clinics

Point-of-Care Facilities

Others

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

Table of Contents
for Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. COMPANION ANIMAL HEALTH MARKET OVERVIEW

    1.1. Study Scope

    1.2. Base Year

    1.3. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. COMPANION ANIMAL HEALTH KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. COMPANION ANIMAL HEALTH INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Market Attractiveness Analysis

    4.3. Regulatory Framework Analysis

    5. COMPANION ANIMAL HEALTH MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. COMPANION ANIMAL HEALTH MARKET – BY ANIMAL TYPE:

    6.1. Overview

    6.2. Equine

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.3. Dogs

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.4. Sheep & Goats

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.5. Cats

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.6. Poultry

    6.6.1. Overview

    6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7. COMPANION ANIMAL HEALTH MARKET – BY PRODUCT:

    7.1. Overview

    7.2. Vaccines

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.3. Pharmaceuticals

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.4. Feed Additives

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.5. Diagnostics

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.6. Others

    7.6.1. Overview

    7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8. COMPANION ANIMAL HEALTH MARKET – BY DRUG:

    8.1. Overview

    8.2. OTC

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3. Prescription

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9. COMPANION ANIMAL HEALTH MARKET – BY DISTRIBUTION CHANNEL:

    9.1. Overview

    9.2. E-commerce

    9.2.1. Overview

    9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9.3. Retail

    9.3.1. Overview

    9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9.4. Hospitals

    9.4.1. Overview

    9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    10. COMPANION ANIMAL HEALTH MARKET – BY APPLICATION:

    10.1. Overview

    10.2. Clinics

    10.2.1. Overview

    10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    10.3. Point-of-Care Facilities

    10.3.1. Overview

    10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    10.4. Others

    10.4.1. Overview

    10.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11. COMPANION ANIMAL HEALTH MARKET– BY GEOGRAPHY

    11.1. Introduction

    11.2. North America

    11.2.1. Overview

    11.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.2.3. U.S.

    11.2.3.1. Overview

    11.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.2.4. Canada

    11.2.4.1. Overview

    11.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.3. Europe

    11.3.1. Overview

    11.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.3.3. France

    11.3.3.1. Overview

    11.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.3.4. Germany

    11.3.4.1. Overview

    11.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.3.5. Rest of Europe

    11.3.5.1. Overview

    11.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.4. Asia Pacific (APAC)

    11.4.1. Overview

    11.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.4.3. China

    11.4.3.1. Overview

    11.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.4.4. India

    11.4.4.1. Overview

    11.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.4.5. Rest of APAC

    11.4.5.1. Overview

    11.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.5. Rest of the World

    11.5.1. Overview

    11.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.5.3. Latin America

    11.5.3.1. Overview

    11.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    11.5.4. Middle East and Africa

    11.5.4.1. Overview

    11.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    12. KEY VENDOR ANALYSIS

    12.1. Merck

    12.1.1. Company Overview

    12.1.2. SWOT Analysis

    12.1.3. Key Developments

    12.2. Nutreco

    12.2.1. Company Overview

    12.2.2. SWOT Analysis

    12.2.3. Key Developments

    12.3. Zoetis

    12.3.1. Company Overview

    12.3.2. SWOT Analysis

    12.3.3. Key Developments

    12.4. Boehringer Ingelheim

    12.4.1. Company Overview

    12.4.2. SWOT Analysis

    12.4.3. Key Developments

    12.5. Bayer AG

    12.5.1. Company Overview

    12.5.2. SWOT Analysis

    12.5.3. Key Developments

    12.6. Virbac

    12.6.1. Company Overview

    12.6.2. SWOT Analysis

    12.6.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    13. 360 DEGREE ANALYSTVIEW

    14. APPENDIX

    14.1. Research Methodology

    14.2. Abbreviations

    14.3. Disclaimer

    14.4. Contact Us

List Of Tables
in Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Companion Animal Health Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Table 10 Companion Animal Health Market, by Animal Type, 2016 – 2027 (USD Million)

Table 11 Companion Animal Health Market, by Product, 2016 – 2027 (USD Million)

Table 12 Companion Animal Health Market, by Drug, 2016 – 2027 (USD Million)

Table 13 Companion Animal Health Market, by Distribution Channel, 2016 – 2027 (USD Million)

Table 14 Companion Animal Health Market, by Application, 2016 – 2027 (USD Million)

Table 15 Companion Animal Health Market, by Geography, 2016 – 2027 (USD Million)

Table 16 North America Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 17 U.S. Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 18 Canada Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 19 Europe Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 20 France Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 21 Germany Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 22 Asia Pacific Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 23 China Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 24 India Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 25 Latin America Companion Animal Health Market, 2016 – 2027 (USD Million)

Table 26 MEA Companion Animal Health Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Companion Animal Health Market, by Animal Type, 2016 – 2027 (USD Million)

Figure 7 Companion Animal Health Market, by Product, 2016 – 2027 (USD Million)

Figure 8 Companion Animal Health Market, by Drug, 2016 – 2027 (USD Million)

Figure 8 Companion Animal Health Market, by Distribution Channel, 2016 – 2027 (USD Million)

Figure 8 Companion Animal Health Market, by Application, 2016 – 2027 (USD Million)

Figure 9 Companion Animal Health Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270579 | AV160

Number of Pages

230

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Companion Animal Care Market: Size, Trends & Forecasts (2017-2021)
Scope of the ReportThe report entitled “Global Companion Animal Care Market: Size, Trends & Forecast...
01 Feb 2017 by Daedal Research USD $800 More Info
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone), Mode of Delivery (Premixes, Oral Powder, Injection), Animal (Food-producing & Companion) - Global Forecast to 2021
The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from ...
12 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
The veterinary vaccines market has seen significant growth over the past few years, due to fear of i...
01 Dec 2016 by Market Data Forecast USD $4,255 More Info
North America Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
The North America animal vaccines market is poised to reach 71.69 Million by 2020 from 07.26 M...
01 Dec 2016 by Market Data Forecast USD $3,335 More Info
Europe Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
The Europe animal vaccines market is poised to reach 40.82 Million by 2020 from 93.64 Million ...
01 Dec 2016 by Market Data Forecast USD $3,335 More Info
Global Companion Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts
The Global Companion Diagnostics Partnering 2010-2016 report provides comprehensive understanding an...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Trends and Innovations in Companion Diagnostics
IntroductionAre companion diagnostics becoming a “must have” for market access? Companion Diagnostic...
01 Apr 2016 by FirstWord Pharma USD $695 More Info
Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020
The report segments the veterinary vaccines market on the basis of products, diseases, technologies,...
09 Jun 2015 by MarketsandMarkets USD $5,650 More Info
Physician Views: How do oncologists use companion diagnostics, what are the key challenges and which pharma companies are best at supporting them?
ScopeAs exemplified by Roche's R&D presentation last week (see Spotlight On: Roche's R&D day – The k...
01 Oct 2013 by FirstWord Pharma USD $695 More Info
Effective sales and marketing strategies for drugs with companion diagnostics
IntroductionTo fully exploit the commercial advantages of companion diagnostics, Pharma companies ne...
01 May 2013 by FirstWord Pharma USD $695 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product (Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others), By Drug, By Distribution Channel, By Application and Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...